4//SEC Filing
Schnoll-Sussman Felice 4
Accession 0001493152-18-003190
CIK 0001054102other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:31 PM ET
Size
7.6 KB
Accession
0001493152-18-003190
Insider Transaction Report
Form 4
Schnoll-Sussman Felice
Director
Transactions
- Award
Stock Option(right to buy)
2018-03-07+19,200→ 19,200 totalExercise: $1.01Exp: 2028-03-07→ Common Stock (19,200 underlying) - Award
Common Stock
2018-03-07+4,800→ 4,800 total
Footnotes (3)
- [F1]The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
- [F2]Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
- [F3]The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.
Documents
Issuer
Interpace Diagnostics Group, Inc.
CIK 0001054102
Entity typeother
Related Parties
1- filerCIK 0001717549
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:31 PM ET
- Size
- 7.6 KB